baber/WOPTO huggingface dataset:
Patent NZ-258591-A (NZ)
Title: Use of idazoxan and derivatives thereof in a medicament for treating parkinsons disease
Inventor: COLPAERT FRANCIS
IPC: A61K31/405
Filed: 1993-12-06
Abstract: A compound of general formula (I), wherein R is a hydrogen atom, a straight or branched C1-4 alkyl radical or a straight or branched C1-4 alkoxy radical; and therapeutically acceptable salts, a racemic mixture or optically active isomers thereof; is used to prepare a drug for treating Parkinson's disease and its development.
Patent NZ-273514-A (NZ)
Title: Method of cryopreservation of cultured tissue
Inventor: WILKINS LEON M
IPC: B65D85/50
Filed: 1994-09-14
Abstract: This invention is directed to cryopreservation of cultured tissue equivalents made by in vitro technology. The invention involves immersing a cultured tissue equivalent in a cooled cryoprotectant solution, agitating the cryoprotectant solution and the immersed cultured tissue to achieve effective penetration of the cryoprotectant solution into the cultured tissue equivalent, and then freezing the cultured tissue at a high freezing rate. The cryopreserved cultured tissue equivalent may be stored for indefinite periods of time prior to use. The cultured tissue equivalent is an in vitro model of the equivalent human tissue, which, when retrieved from storage can be used for transplantation or implantation in vivo or for screening compounds in vitro.
Patent NZ-291508-A (NZ)
Title: Isoxazoles; preparation and medicaments
Inventor: KOJIMA KOICHI
IPC: A61K31/42
Filed: 1995-08-29
Abstract: The isoxazole derivative having the following general formula: <CHEM> Äwherein R<1> represents a hydrogen atom; halogen atom; alkyl group; alkoxy group; hydroxyl group; alkylthio group; amino group; alkanoyl group; alkanoylamino group; alkanoyloxy group; alkoxycarbonyl group; carboxy group; (alkylthio)thiocarbonyl group; carbamoyl group; nitro group; or cyano group; R<2> represents an amino group; m represents an integer of from 1 to 3; n represents an integer of from 1 to 6; ring A represents a phenyl ring, a naphthyl ring or an aromatic heterocycle; X represents an oxygen atom or a sulfur atomÜ has an excellent monoamine oxidase inhibitory activity, and is useful as a therapeutic agent or a preventive agent against neuropathies (Parkinson's disease) and the like.
Patent NZ-331662-A (NZ)
Title: Printing a metallic layer on the surface of a detail for shielding against electromagnetic radiation
Inventor: ERIKSSON LARS
IPC: H05K3/12
Filed: 1997-03-04
Abstract: A method of placing a metallic layer on a detail, which shields against electromagnetic radiation, is characterised in that the layer is transferred with a predetermined spread in a predetermined pattern on to the detail by a known printing method, e.g. tampon printing whereby a printing pad 1 is used.  The printing pad can have different shapes with at least one non-flat surface 5 in order to be able to transfer the metallic layer on its surface 3 on to different shapes of surfaces which are found in, for example, a detail 8 in the shape of a telephone casing.
Patent NZ-331841-A (NZ)
Title: An elongate linear elastomeric fender comprising a plurality of tubes of differing membrane compressibility
Inventor: BEXKETT ROBERT PRENTICE
IPC: F16F1/44
Filed: 1997-05-15
Abstract: An elongate linear elastomeric fender comprising an outer sheath surrounding a core, wherein the core comprises a plurality of tubes, and the outer sheath has a higher compressibility than the core, is described. The fender can be flexible and continuous, providing ease of transport and installation. The different layers of the fender provide different absorption of kinetic energy upon impact, and also dissipate impact energy transversely throughout the fender.
Patent NZ-336402-A (NZ)
Title: Child resistant cigarette lighter with piezoelectric ignition of fuel, resistant spring increases force necessary to produce spark
Inventor: LAFOREST GUY
IPC: H01L41/113
Filed: 1997-12-17
Abstract: piezoelectric ignition mechanism for a cigarette lighter has inner 14 and outer 12 telescopic members.  The inner member includes a piezoelectric element 24, while the outer element includes a plexor 28 which, when released strikes an impact pad 26 which passes the impact to the piezoelectric element.  The inner and outer elements are biased away from each other by return spring 16.  When the lighter is operated, inner member 14 presses on lug 34 attached to plexor 28.  This forces plexor 28 downwards, compressing spring 30.  At a predetermined point, the plexor is released allowing it to be moved upwards by spring 30 to strike the impact pad.  A resistant spring 50 provides extra resistance to the downwards movement of inner member 14, the extra force being to much for a child to overcome.  This makes it more difficult for a child to use the lighter.
Patent NZ-505707-A (NZ)
Title: Coin discrimination apparatus and method
Inventor: MARTIN DOUG
IPC: G07D3/14
Filed: 1997-06-27
Abstract: Coins travel along a rail. Pin (or rake) 2152 is movable from a normal position retracted out of the coin path to a position within the coin path.  A motive device (not shown) is coupled to the pin to move it between these positions.
Patent NZ-506535-A (NZ)
Title: Roof construction includes adjustable support plate for glazing bars
Inventor: RICKMAN PAUL DOUGLAS
IPC: E04B7/04
Filed: 1999-03-12
Abstract: A conservatory roof construction includes a ridge member 12 and a plurality of glazing bars 13 each extending away from and having one end supported by ridge member 12.  One end of each glazing bar 13 bears on a respective support plate 46 pivoted to ridge member 12.  There is means for selectively setting the relative angle between plate 46 and ridge member 12.  The means comprises an arcuate receptor 50 centred on the pivot axis of support plate 46, having a plurality of spaced engagement means with any one of which the end of the support plate remote from its pivotal connection to the ridge member may be engaged.
Patent NZ-509161-A (NZ)
Title: Animated image passes through winning combination in video gaming machine display
Inventor: TIMPERLEY DAVID
IPC: G07F17/32
Filed: 1999-06-04
Abstract: A gaming console includes a video display and a game controller that controls game images displayed on the display. To play a game a plurality of symbols are randomly selected and displayed on the display and if a winning combination results, the console pays a prize. The game is of a style that creates a matrix of symbols and pays prizes for the occurrence of predetermined combinations in the matrix, winning combinations being highlighted to indicate the combination to the player. The winning combination is highlighted and indicated to the player by creating an animated image of a path 60 on the display, which indicates each symbol of the respective winning combination and which is superimposed over the images of the symbols.
Patent NZ-509279-A (NZ)
Title: method and machine for making a string of bags provided with transverse closure profiles and resulting articles
Inventor: BOIS HENRI GEORGES
IPC: B31B19/90
Filed: 1999-07-09
Abstract: A method of manufacturing a string of bags provided with transverse closure strips, the method comprising the steps which consist in sequentially placing closure system segments transversely on at least one film for forming the walls of the bag, each segment comprising two complementary closure strips, in fixing one or more support webs of the two complementary closure strips respectively to the inside faces of the two walls of the bag, and in providing sequential transverse openings through part of the film so as to give access to between the two strips from the outside of the closure system relative to each bag.
Patent NZ-509610-A (NZ)
Title: Process for purifying human papillomavirus virus-like particles using hydroxyapatite
Inventor: COOK JAMES C
IPC: C12N7/02
Filed: 1999-08-10
Abstract: A process for purifying papillomavirus virus-like particles (VLPs) includes the step of passing a partially purified VLP-containing solution through a hydroxyapatite chromatography column. The VLPs are then eluted using a buffer containing phosphate anions. This method recovers a high yield of intact VLPs.
Patent NZ-510196-A (NZ)
Title: Substituted imidazo[1,2-a]pyridines, pyrimidines or triazines useful as selective inhibitors of cox-2
Inventor: FARRERONS GALLEMI CARLES
IPC: A61P43/00
Filed: 1999-07-23
Abstract: A substituted imidazo [1,2a] azine of formula (I), where: A and B are N or CH, with the condition that when A is N, B is N; R1 is CH3 or NH2; R2 and R3 are H, CH3, Br, Cl, COCH3 or OCH3; R4, R5 and R6 are H, F, Cl, Br, (C1-C3)-alkyl, trifluoromethyl, (C1-C3)-alkoxy or trifluoromethoxy. These compounds selectively inhibit COX-2 over COX-1.  They may be used for the treatment of inflammation or cyclooxygenase-mediated diseases, colon cancer, and may reduce potential for ulcerogenic effects.
Patent NZ-513420-A (NZ)
Title: Non stain flooring with particulate material to reduce slip
Inventor: SHORTLAND ADRIAN JOHN
IPC: D06N7/00
Filed: 2000-01-11
Abstract: A method of making a plastic flooring material (1) comprising a base portion (2) which comprises a PVC plastisol material, a non-stratified coating portion (3) imparting stain resistance to the flooring material being positioned in contact with an upper surface of the base portion and creating an upper surface of the flooring material, and a first particulate material (6) embedded in the coating portion and partially penetrating the base portion to provide a roughening effect of the upper surface of the flooring material for enhancing slip resistance and protection from wear.  The coating (3) merges into the base portion where they meet at joint (4) to form a stratified portion (5).  The method comprising the steps of: (a) Mixing together the components of the base portion; (b) Spreading the mixed components of the base portion on a surface; (c) Carrying out at least one application of a particulate material to the components of the base portion to at least partially penetrate the base portion; (d) Gelling or Curing the base portion; (e) Carrying out at least one application of components of the coating portion in powder form; (f)  Heating the powder coated base portion to cause the powder coating to form a film.
Patent NZ-520586-A (NZ)
Title: Method of gradually reducing or eliminating tobacco smoking habit
Inventor: KYLE THEODORE K
IPC: A61K9/72
Filed: 2001-02-15
Abstract: A method for reducing or eliminating tobacco usage and the nicotine dependency associated with tobacco usage by gradually decreasing an individual's tobacco consumption over a time period while replacing nicotine from tobacco with an alternative nicotine source is disclosed.
Patent NZ-521708-A (NZ)
Title: Controlling growth of fungi and mildew by combining an aqueous system with strobilurin
Inventor: CASH HOWARD
IPC: D21H17/03
Filed: 2001-03-23
Abstract: The use of strobilurin or oudemansin antifungal agents as biocides in aqueous systems is disclosed. The aqueous systems include wet-lap preservation, mould proofing, mildew proofing, and other uses where anti-fungal and/or anti-mildew activity is desired. Aqueous systems treatable with strobilurins and/or oudemansins include pulp and paper systems, oil and gas systems, cooling towers, and heat exchangers.
Patent NZ-530854-A (NZ)
Title: Improved CC-1065 analog synthesis
Inventor: CHARI RAVI V J
IPC: A61P31/04
Filed: 2003-03-19
Abstract: A process is described for preparing a compound of formula (I), or a salt thereof, which comprises the following steps: (a) providing a compound of formula (II), wherein R is a protecting group; (b) performing halogenation, alkylation and ring-closure reactions upon compound (II) under suitable conditions to provide racemate (III); (c) isolating the (-) isomer of racemate (III); and (d) removing said R protecting groups from the isolated (-) isomer of compound (III) under suitable conditions to produce compound (I). A process for preparing DC1 or an analog of DC1 is also described which comprises the step of reacting the amino group of a compound of formula (I) to form a peptide bond. The peptide bond is formed by reacting the amino group of compound (I) with the carboxyl group of compound (IV) wherein R1 is a thiol group capable of forming a disulfide bond within compound (IV), and whereby DC1 is prepared.
Patent NZ-534094-A (NZ)
Title: Method and apparatus of manufacturing glued laminated wood
Inventor: ABE YUKIO
Filed: 2004-07-12
Abstract: A method and an apparatus of wood pressing usable in manufacturing glued laminated wood such as laminated veneer lumber (LVL) using a number of wood veneer sheets are disclosed. A hot press (141) used for wood pressing includes a pair of heating plates (143,155) which are disposed one above the other and have pressing surfaces facing each other. The paired heating plates are both movable toward and away from each other. In operation, firstly one of the heating plates is moved toward the other heating plate to a position where the pressing surface of the one heating plate is spaced from a surface to which a veneer sheet is to be glued by a distance corresponding to the thickness of the veneer sheet. Then, the other heating plate is moved toward the one heating plate until a desired pressure is produced pressing.
Patent NZ-537271-A (NZ)
Title: A method of inhibiting blood or serum coagulation in vitr
Inventor: VLASUK GEORGE P
IPC: C07K14/81
Filed: 1995-10-17
Abstract: Proteins that have activity as anticoagulants and/or serine protease inhibitors and have at least one NAP can be isolated from natural sources as nematodes, chemically synthesized or made by recombinant methods using various DNA expression systems. Certain of these proteins have factor Xa inhibitory activity and others have activity as inhibitors of factor VIIa/TF. The proteins can be used in a method for inhibiting caogulation of blood or serum in vitro or in non-human animals.
Patent NZ-539642-A (NZ)
Title: Compositions containing extracts from hops in combination with a second component for treating inflammatory response
Inventor: TRIPP MATTHEW L
IPC: A61K31/19
Filed: 2003-10-20
Abstract: Disclosed is a composition comprising: as a first component, a fraction isolated or derived from hops; and as a second component, at least one member selected from the group consisting of rosemary, an extract derived from rosemary, a compound derived from rosemary, and a triterpine species. Compositions of the type disclosed are useful for inhibiting the expression of COX-2, inhibiting the synthesis of prostaglandins in target cells, inhibit inflammatory responses selectively in target cells and/or NFkappaB activation selectively in target cells.
Patent NZ-539800-A (NZ)
Title: A teat mounting
Inventor: REID BRUCE DOUGLAS
Filed: 2005-05-05
Abstract: A mounting 10 for a screw-in calf teat has a threaded internal bore into which the thread of the teat can screwed and a mounting spigot and flange 16 which seats within and is mounted to a turret T protruding from the wall W of the feed container. Thus the same arrangement of turret and cap 20 which is used to mount a flanged teat can, in combination with the mounting 10, be used to mount a screw-in teat to the feed container wall. In one embodiment the cap 20 is integral with the mounting 10.
Patent NZ-540676-A (NZ)
Title: Polypeptide that reduces 15-keto prostaglandin but not leukotriene B4 useful for treating PPAR related diseases
Inventor: CHUANG LEE-MING
IPC: C12N15/09
Filed: 2005-06-09
Abstract: Described is an isolated polypeptide containing the sequence of SEQ ID NO: 1 or a functional equivalent of SEQ ID NO: 1, in which the polypeptide reduces 15 -keto prostaglandin but not leukotriene B4. Also disclosed is an antibody that binds specifically to the polypeptide and a double-stranded ribonucleic acid for inhibiting expression of the 15-keto prostaglandin-Ä13-reductase.
Patent NZ-544820-A (NZ)
Title: Piperazine with or-substituted phenyl group and their use as GlyT1 inhibitors
Inventor: JOLIDON SYNESE
IPC: C07D257/04
Filed: 2004-08-02
Abstract: Disclosed is a compound of formula (I) or pharmaceutically acceptable salts thereof, where the ring Ar contains one to three nitrogen atoms, and wherein the rest of the subtituents are disclosed in the specification. Also disclosed is a process for making such compounds. Also disclosed is the suitability of the above compound for treating illnesses based on the glycine uptake inhibitor, such as psychoses, pain, disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.
Patent NZ-545470-A (NZ)
Title: Lipid system and methods of use
Inventor: MUSTAD VIKKIE A
IPC: A23L1/30
Filed: 2004-08-04
Abstract: Disclosed is a composition of omega-3, omega-6, and omega-9 fatty acids, where the ratio of omega-6 to omega-3 is between 0.25:1 and 3:1, the ratio of omega-9 to omega-3 is between 0.4:1 and 3:1, wherein the composition comprises 17-54% of the omega-3 fatty acid alpha-linolenic acid, 17-21% of the omega-6 fatty acid linoleic acid, and 19-52% if the omega-9 fatty acid oleic acid. Also disclosed in the use if this composition to improve glucose tolerance in glucose intolerant individuals, to improve insulin sensitivty in insulin resistant individuals, to reduce the risk of vascular disease, or as a general nutritional composition.
Patent NZ-548928-A (NZ)
Title: A plaything
Inventor: DALLINGER REBECCA JANE
Filed: 2006-08-03
Abstract: Described is a plaything which includes a first object and at least one further object. The first object, at least partially includes an exterior surface made from a textile wherein all or a portion of the textile has temporary magnetic properties ('a magnetic textile'); and the magnetic textile has similar properties of flexibility as the textile would have without addition of magnetic properties. During use, at least one further object with permanent magnetic properties can be attached and detached from the first object, characterised in that the attachment point may be anywhere on the magnetic textile of the first object.
Patent NZ-554904-A (NZ)
Title: In-situ forming implant for animals
Inventor: SAUTTER CAROLINE
IPC: A61K9/08
Filed: 2005-12-13
Abstract: Provided is a composition for forming a solid implant in situ within a body by exposure to body fluids, suitable for a controlled release of bioactive material, comprising (i) a biologically active agent, (ii) 10 to 25% by weight of the total composition of a pharmaceutically acceptable, biodegradable, thermoplastic polymer, which is a polylactide which is insoluble in aqueous media or human or animal body fluids, (iii) 50 to 80% by weight of the total composition of a pharmaceutically acceptable, biodegradable, water-insoluble or slightly water-soluble organic solvent, which is a triester of glycerin, and (iv) above 0 to up to 10% by weight of the total composition a pharmaceutically acceptable, water-soluble and biocompatible adjuvant selected from the group consisting of C2-C6alkanols, polyhydroxy alcohols and ketals. Further provided are implants made of said composition and a method of implanting the implant in a non-human animal body.
Patent NZ-561648-A (NZ)
Title: Methods and composition of IGF1R inhibitors for treating or preventing cancer
Inventor: WANG YAOLIN
IPC: A61K33/243
Filed: 2006-04-14
Abstract: Disclosed is a use of one or more IGF1R inhibitors for manufacture of a medicament for treating or preventing a medical condition, in a mammalian subject, selected from the group consisting of neuroblastoma, rhabdomyosarcoma, and osteosarcoma.
Patent NZ-568937-A (NZ)
Title: Detecting voltage ringing in an inductive load for a dimmer
Inventor: VANDERZON JAMES ROBERT
IPC: H02H3/20
Filed: 2006-12-12
Abstract: A circuit (3) for detecting the presence of an inductive load. The circuit includes a detector (10) for detecting a voltage ringing signal across an inductive load (30) and a filter for extracting a voltage ringing signal which filters out a line voltage frequency in a signal across the inductive load (30). The circuit (3) further includes a peak detector for detecting peaks in the voltage ringing signal and a signal generator for generating a signal indicating the presence of an inductive load when voltage ringing is detected.
Patent NZ-571691-A (NZ)
Title: Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
Inventor: EDWARDS JAMES P
IPC: C07D401/14
Filed: 2007-03-30
Abstract: Disclosed are benzoimidazol-2-yl pyrimidines and pyrazines represented by general formula (I), or pharmaceutically acceptable salts thereof. Also disclosed is the use of the compounds of formula (I) for treating a disease or disorder mediated by histamine H4 receptor activity. Such disorders or diseases include inflammatory disorders, allergic disorders, dermatological disorders, autoimmune disease, lymphatic disorders and immunodeficiency disorders.
Patent NZ-577761-A (NZ)
Title: Pharmaceutical preparation for the alleviation of endometriosis
Inventor: SEITZ CHRISTIAN
IPC: A61P15/00
Filed: 2008-02-23
Abstract: Disclosed is the use of 17alpha-Cyanomethyl-17-beta-hydroxyestra-4,9-diene-3-one (Dienogest) for the manufacture of a pharmaceutical product for monophasic continuous administration of 2 mg Dienogest daily for at least 169 days or 25 weeks to several years to treat endometriosis.
Patent NZ-580962-A (NZ)
Title: 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
Inventor: SOARES DA SILVA PATRICIO MANUEL VIEIRA ARAUJO
IPC: A61P25/22
Filed: 2008-05-06
Abstract: Disclosed are compounds of formula I, R and S enantiomers thereof, and methods for their preparation. A specific example of formula I is (R)-5-(2-(benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione. Also disclosed is a process for the preparation of the individual R and S enantiomers of formula I from the reaction of the terminal primary amine precursor with an aldehyde under reductive alkylation conditions. Compounds of formula I are useful for reducing the hydroxylation of dopamine to noradrenaline, treating anxiety disorders, migraine, cardiovascular disorders, hypertension, chronic or congestive heart failure, angina, arrhythmias, circulatory disorders, Raynaud's phenomenon and inhibiting dopamine-beta-hydroxylase.